[1]
S. Lee, PharmD, V. Tatla, PharmD, S. Buga, MD, and D. Pon, PharmD, BCOP, BCPS, “Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients”, J of Opioid Management, vol. 18, no. 6, pp. 497–502, Nov. 2022.